Institut Jules Bordet Unite du Chimiotherapie

Brussels 1000

0 studies enrolling now · 3 studies all time

What they study most

Advanced Breast Cancer, Advanced Malignant Solid Tumors, Breast Cancer, Breast Neoplasms, Neoplasms

Studies at this site

• Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer — Completed
• Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer — Completed
• A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer — Completed